Kintara Therapeutics, Inc.

Seeking New Horizons for Cancer Patients

Kintara Therapeutics is dedicated to the development of novel cancer therapies for patients who are failing or resistant to current treatment regimens.

Learn How We are Making a Difference

Latest Updates

Latest Press Release

View All Press Releases

Posters

View All Posters

Recent News

View All Recent News

Unlocking the Promise of Biology

Kintara Therapeutics has teamed up with outstanding academic and clinical research institutions from around the world to support the development of our novel solid tumor cancer therapies.

View Our Academic Collaborations

Late-Stage Therapeutic for Oncology Indication with Unmet Medical Need

REM-001 is a second-generation photosensitizer drug possessing multiple advantages over earlier generation PDT compounds.

View Our Ongoing Clinical Trial

An Experienced Team with a Track Record of Success

Kintara Therapeutics' leadership team is committed to contributing to the battle against cancer by researching and developing novel cancer therapies that treat patients with significant unmet clinical needs.

Management Team
Board of Directors
Scientific Advisory Board
Advisors

Stock Information

View Investor Relations View Investor Presentation